scorecardresearch
Wednesday, August 13, 2025
TopicMylan

Topic: Mylan

Pharma giant Mylan wants hepatitis C drug’s clinical trial for Covid waived, regulator says no

Low-cost hepatitis C drugs sofosbuvir, used in combination with daclatasvir, has shown promise in reducing chance of death among hospitalised Covid patients.

How India’s culture of ‘jugaad’ is challenging the US drug agency

'Jugaad', translated as creative improvisation, is credited with the rise in technology and drug making in India. But it can have a darker connotation -- get it done at all costs.

On Camera

US bullying spurred Green Revolution. Let tariffs give us a Business Revolution

Perhaps the present crisis and trauma can force our country into something resembling that special moment we found in the sixties. Perhaps we can radically alter our business environment.

How mining, manufacturing & power sectors weighed on India’s industrial output since January 2024

India’s industrial output growth saw a 10-month low in June, with Index of Industrial Production (IIP) growing by mere 1.5% as against 1.9% in May 2025.

India expands Southeast Asia defence footprint with new joint venture in Philippines

Memorandum of understanding between SMPP and ADFC was signed during state visit of Philippines’ President to India earlier this month.

Modi’s ready to risk it all for farmers. Farm reform can answer Trump with new Green Revolution

Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.